| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.4M | — | +214.8% |
| R&D Expense | $0 | — | -100.0% |
| SG&A Expense | $7.7M | — | +22.8% |
| Operating Income | $6.5M | — | +202.4% |
| Interest Expense | $174K | — | -86.9% |
| Pre-tax Income | $6.1M | — | +175.6% |
| Income Tax | $0 | — | +100.0% |
| Net Income | $3.1M | — | +185.0% |
| EPS (Basic) | $0.05 | — | +150.0% |
| EPS (Diluted) | $0.05 | — | +138.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.2M | -37.0% | +6.1% |
| Accounts Receivable | $5.5M | +46.9% | +768.8% |
| Current Assets | $10.5M | +1.2% | +295.3% |
| Total Assets | $62.4M | -6.5% | +9.9% |
| Current Liabilities | $23.4M | -17.9% | -55.1% |
| Long-term Debt | $7.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.8M | — | -391.2% |
| Capital Expenditures | $12K | — | -87.0% |
| Investing Cash Flow | $1.2M | — | +1442.2% |
| Financing Cash Flow | $849K | — | +241.3% |
| Free Cash Flow | -$2.8M | — | -424.0% |
| -75.5% |
| Total Liabilities | $32.7M | -23.8% | -60.5% |
| Stockholders' Equity | $14.9M | +25.1% | +228.6% |